HEALTH

Switching off the pain

BY Michael Johnsen

LAKE FOREST, Ill. — Omron recently charged analgesic aisles with a new pain relief option. Omron’s Electro-Therapy Pain Relief unit is the only approved transcutaneous electrical nerve stimulation unit on the market and should be an adjunctive sale for chronic pain sufferers. The product could add a spark to nonmedicinal, external pain relief. Sales of heat and ice packs were relatively flat in 2012, with sales approaching $235 million.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

At-home tests grow in popularity

BY Michael Johnsen

BETHLEHEM, Pa. — The landmark launch of Orasure Technologies’ OraQuick In-Home HIV test last year was a key driver behind the 5.4% growth in the home-test kit category for the 12 weeks ended Dec. 30 across U.S. multi-outlets, according to SymphonyIRI Group data. The HIV test contributed $1 million in purely incremental sales to the total $15.5 million in category sales.

OraQuick contributes to a trend of more self-test diagnostic tools coming to market. According to Identigene, which manufactures a DNA test kit, there are three factors behind self testing — the continued shortage of family care physicians, the number of patients without insurance or who are under-insured and the proliferation of retail clinics, which is contributing to awareness of diagnostic options in the pharmacy.

 

The article above is part of the DSN Category Review Series. For the complete Diagnostics Sell-Through Report, including extensive charts, data and more analysis, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Glucose meter sales follow diabetes increase

BY Michael Johnsen

Sales of glucose meters were slightly up over the holidays, reaching $67.7 million for the 12 weeks ended Dec. 30 across U.S. multi-outlets, according to SymphonyIRI Group data.

With a new diabetes diagnosis being made once every 21 seconds, coupled with the coming expansion of Medicaid requirements across at least some states, there will be a significant consumer demand for blood-glucose meters and the test strips that supply them for some time to come.

So it can’t hurt having earned a "highest satisfaction" rating from J.D. Power and Associates’ inaugural 2012 Blood-Glucose Meter Satisfaction Survey. That was a distinction earned by Roche Diagnostics’ Accu-Chek meter, with Abbott Diabetes Care’s Freestyle and Bayer Diabetes Care’s Countour meters ranking No. 2 and No. 3, respectively.

Out of Roche’s Accu-Chek brand family, Aviva Plus has been earning "highest satisfaction" at the register, generating $3.3 million across the fourth quarter of 2012, according to SymphonyIRI Group data.

 

The article above is part of the DSN Category Review Series. For the complete Diagnostics Sell-Through Report, including extensive charts, data and more analysis, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?